{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:23Z","timestamp":1791489623322,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd011367","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T00:00:00Z","timestamp":1506902400000}}],"reference-count":91,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011367.pub2","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T12:13:34Z","timestamp":1506946414000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Intravenous immunoglobulin for the treatment of childhood encephalitis"],"prefix":"10.1002","volume":"2017","author":[{"given":"Mildred A","family":"Iro","sequence":"first","affiliation":[{"name":"University of Oxford and the NIHR Oxford Biomedical Research Centre; Department of Paediatrics; Churchill Hospital, Old Road, Headington Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie G","family":"Martin","sequence":"additional","affiliation":[{"name":"Christchurch School of Medicine, University of Otago; Department of Paediatrics; Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Absoud","sequence":"additional","affiliation":[{"name":"Evelina London Children's Hospital, Guy's and St Thomas' Hospital, King's Health Partners; Children's Neurosciences Centre; Westminster Bridge Road London England UK SE1 7EH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Pollard","sequence":"additional","affiliation":[{"name":"Children's Hospital; Department of Paediatrics, University of Oxford; Oxford UK OX3 9DU"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD011367.pub2-BIB0001|cit1","first-page":"816","article-title":"The clinical observation of high dose immunoglobulin for children viral encephalitis","volume":"13","author":"Chen","year":"2006","journal-title":"Chinese Journal of Primary Medicine and Pharmacy"},{"issue":"4","key":"10.1002\/14651858.CD011367.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"e0122608","DOI":"10.1371\/journal.pone.0122608","article-title":"A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal","volume":"10","author":"Rayamajhi","year":"2015","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0003|cit3","first-page":"3127","article-title":"Comparison of the clinical efficacy of immunoglobulin and interferon in the treatment of hand foot and mouth disease complicated with viral encephalitis","volume":"21","author":"Wu","year":"2014","journal-title":"Chinese Journal of Primary Medicine and Pharmacy"},{"issue":"8","key":"10.1002\/14651858.CD011367.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00246-012-0350-4","article-title":"Use of intravenous immunoglobulin compared with standard therapy is associated with improved clinical outcomes in children with acute encephalitis syndrome complicated by myocarditis","volume":"33","author":"Bhatt","year":"2012","journal-title":"Pediatric Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD011367.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pediatrneurol.2013.03.021","article-title":"Acute disseminated encephalomyelitis in children and adolescents: a single center experience","volume":"49","author":"Erol","year":"2013","journal-title":"Pediatric Neurology"},{"issue":"26","key":"10.1002\/14651858.CD011367.pub2-BIB0006|cit6","first-page":"1291","article-title":"Preliminary results of the use of human anti-measles immunoglobulin in measles encephalitis","volume":"26","author":"Gelli","year":"1974","journal-title":"Minerva Pediatrica"},{"issue":"4","key":"10.1002\/14651858.CD011367.pub2-BIB0007|cit7","first-page":"359","article-title":"Multimodal treatment of acute disseminated encephalomyelitis in children","volume":"8","author":"Girija","year":"2010","journal-title":"Journal of Pediatric Neurology"},{"issue":"3","key":"10.1002\/14651858.CD011367.pub2-BIB0008|cit8","first-page":"253","article-title":"Acute disseminated encephalomyelitis: an evaluation of 15 cases in childhood","volume":"55","author":"\u0130ncecik","year":"2013","journal-title":"Turkish Journal of Pediatrics"},{"issue":"306","key":"10.1002\/14651858.CD011367.pub2-BIB0009|cit9","first-page":"1","article-title":"May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?","volume":"13","author":"R\u016f\u017eek","year":"2013","journal-title":"BMC Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011367.pub2-BIB0010|cit10","first-page":"396","article-title":"Acute disseminated encephalomyelitis in children. A descriptive study in Tehran, Iran","volume":"28","author":"Samileh","year":"2007","journal-title":"Saudi Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD011367.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1442-200x.2004.01872.x","article-title":"Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis associated with hepatitis A infection","volume":"46","author":"Unay","year":"2004","journal-title":"Pediatrics International"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0012|cit12","first-page":"118","article-title":"The clinical observation of the high dose intravenous immunoglobulin for severe viral encephalitis","volume":"02","author":"Fan","year":"2010","journal-title":"Internal Medicine of China"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0013|cit13","unstructured":"NCT02308982 Investigating the role of early intravenous immunoglobulin treatment for children with encephalitis clinicaltrials.gov\/ct2\/show\/record\/NCT02308982"},{"issue":"1","key":"10.1002\/14651858.CD011367.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1352458512445944","article-title":"Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features","volume":"19","author":"Absoud","year":"2013","journal-title":"Multiple Sclerosis"},{"issue":"4","key":"10.1002\/14651858.CD011367.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/tropej\/47.4.243","article-title":"Long term neurological outcome of acute encephalitis","volume":"47","author":"Aygun","year":"2001","journal-title":"Journal of Tropical Pediatrics"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-5728(96)00133-6","article-title":"Increased in vitro uptake of the complement C3b in the serum of patients with Guillain-Barr\u00e9 syndrome, myasthenia gravis and dermatomyositis","volume":"71","author":"Basta","year":"1996","journal-title":"Journal of Neuroimmunology"},{"issue":"4","key":"10.1002\/14651858.CD011367.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nm836","article-title":"F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins","volume":"9","author":"Basta","year":"2003","journal-title":"Nature Medicine"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0018|cit18","volume-title":"Bayley Scales of Infant and Toddler Development. Technical Manual","author":"Bayley","year":"2006"},{"issue":"6","key":"10.1002\/14651858.CD011367.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/neu.2011.2272","article-title":"Validity of a pediatric version of the Glasgow Outcome Scale - Extended","volume":"10","author":"Beers","year":"2012","journal-title":"Journal of Neurotrauma"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0020|cit20","unstructured":"British National Formulary Publications British National Formulary for Children (BNF for Children). Chapter 5.3.2: Herpesvirus infections; page 326 London (UK) British Medical Association, the Royal Pharmaceutical Society, the Royal College of Paediatrics and Child Health, the Neonatal and Paediatric Pharmacists Group"},{"issue":"12","key":"10.1002\/14651858.CD011367.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1086\/509644","article-title":"Role of intravenous immunoglobulin administration in Japanese encephalitis","volume":"43","author":"Caramello","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD011367.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.4049\/jimmunol.1102422","article-title":"Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection","volume":"188","author":"Cervantes-Barrag\u00e1n","year":"2012","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2006-05-023796","article-title":"A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?","volume":"109","author":"Crow","year":"2007","journal-title":"Blood"},{"issue":"6 Suppl 5","key":"10.1002\/14651858.CD011367.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1212\/WNL.51.6_Suppl_5.S2","article-title":"Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases","volume":"51","author":"Dalakas","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2004.04.002","article-title":"The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile","volume":"102","author":"Dalakas","year":"2004","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD011367.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3201\/eid0902.020218","article-title":"Viral encephalitis in England, 1989-1998: what did we miss?","volume":"9","author":"Davison","year":"2003","journal-title":"Emerging Infectious Diseases"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virol.2013.08.030","article-title":"Role of CD25(+) CD4(+) T cells in acute and persistent coronavirus infection of the central nervous system","volume":"447","author":"Aquino","year":"2013","journal-title":"Virology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1172\/JCI114483","article-title":"Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies","volume":"85","author":"Dietrich","year":"1990","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0029|cit29","unstructured":"Dowell E Easton A Solomon T The consequences of encephalitis. Report of a Postal Survey (Year 2000 survey) carried out by the Encephalitis Support Group www.encephalitis.info\/images\/iPdf\/Research2\/CONSEQUENCES1.pdf"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/12.suppl_B.9","article-title":"The biochemistry and mechanism of action of acyclovir","volume":"12 Suppl B","author":"Elion","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jmv.1890410503","article-title":"Acyclovir: discovery, mechanism of action, and selectivity","volume":"Suppl 1","author":"Elion","year":"1993","journal-title":"Journal of Medical Virology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/INF.0b013e31825b129b","article-title":"Steroids and childhood encephalitis","volume":"31","author":"Esposito","year":"2012","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0033|cit33","unstructured":"US Food Drug Administration Immune globulin intravenous (IGIV) indications. Page last updated: 6 October 2013 www.fda.gov\/BiologicsBloodVaccines\/BloodBloodProducts\/ApprovedProducts\/LicensedProductsBLAs\/FractionatedPlasmaProducts\/ucm133691.htm"},{"issue":"4","key":"10.1002\/14651858.CD011367.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1542\/peds.2009-3188","article-title":"Long-term outcomes of acute encephalitis in childhood","volume":"126","author":"Fowler","year":"2010","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejpn.2007.12.009","article-title":"Childhood encephalitis in Sweden: etiology, clinical presentation and outcome","volume":"12","author":"Fowler","year":"2008","journal-title":"European Journal of Paediatric Neurology: EJPN"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00430-012-0229-2","article-title":"Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines","volume":"201","author":"Frenzel","year":"2012","journal-title":"Medical Microbiology and Immunology"},{"issue":"2","key":"10.1002\/14651858.CD011367.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/dmcn.13349","article-title":"Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders","volume":"59","author":"Gadian","year":"2017","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0028-3908(03)00279-X","article-title":"MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS","volume":"45","author":"Glezer","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0039|cit39","unstructured":"GRADE Working Group, McMaster University GRADEprofiler (GRADEpro) 2014"},{"issue":"12","key":"10.1002\/14651858.CD011367.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD011367.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2012-303807","article-title":"Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens","volume":"84","author":"Hacohen","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.25626","article-title":"N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse","volume":"29","author":"Hacohen","year":"2014","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0043|cit43","volume-title":"ABAS\u00ae-II Adaptive Behavior Assessment System\u00ae","author":"Harrison","year":"2003"},{"issue":"414","key":"10.1002\/14651858.CD011367.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistencies in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0045|cit45","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011367.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2249.2009.04025.x","article-title":"Clinical applications of intravenous immunoglobulins in neurology","volume":"158","author":"Hughes","year":"2009","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0047|cit47","unstructured":"International Conference on Harmonisation ICH harmonised tripartite guideline clinical safety data management: definitions and standards for expedited reporting E2A. Current step 4 version. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. 27 October 1994 www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E2A\/Step4\/E2A_Guideline.pdf"},{"issue":"4","key":"10.1002\/14651858.CD011367.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1473-3099(17)30114-7","article-title":"30-year trends in admission rates for encephalitis in children in England and effect of improved diagnostics and measles-mumps-rubella vaccination: a population-based observational study","volume":"17","author":"Iro","year":"2017","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/jnnp.2004.049676","article-title":"Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis","volume":"76","author":"Kamei","year":"2005","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"48","key":"10.1002\/14651858.CD011367.pub2-BIB0051|cit51","first-page":"2913","article-title":"Intravenous acyclovir (ACV, Zovirax) therapy of varicella zoster infections in immunologically endangered patients","volume":"124","author":"Kerpel-Fronius","year":"1983","journal-title":"Orvosi Hetilap"},{"issue":"2","key":"10.1002\/14651858.CD011367.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/341301","article-title":"Burden of encephalitis-associated hospitalizations in the United States, 1988-1997","volume":"35","author":"Khetsuriani","year":"2002","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD011367.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00005344-200401000-00010","article-title":"Effects of immunoglobulin upon murine myocarditis caused by influenza A virus: superiority of intact type to F(ab')2 type","volume":"43","author":"Kishimoto","year":"2004","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-3148.2002.00360.x","article-title":"In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations, a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases","volume":"12","author":"Krause","year":"2002","journal-title":"Transfusion Medicine (Oxford, England)"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0055|cit55","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins J, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Lewthwaite P Begum A Ooi M Faragher B Lai BF Sandaradura I Disability after encephalitis: development and validation of a new outcome score Bulletin of the World Health Organization 2010 584 92","DOI":"10.2471\/BLT.09.071357"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000350572","article-title":"Are steroids a beneficial adjunctive therapy in the immunosuppressed patient with herpes simplex virus encephalitis?","volume":"5","author":"Lizarraga","year":"2013","journal-title":"Case Reports in Neurology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.beha.2005.01.032","article-title":"Use of intravenous immunoglobulin G (IVIG)","volume":"19","author":"Looney","year":"2006","journal-title":"Best Practice & Research. Clinical Haematology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1128\/JVI.00619-08","article-title":"The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis","volume":"82","author":"Lundberg","year":"2008","journal-title":"Journal of Virology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood.V88.1.184.184","article-title":"High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes","volume":"88","author":"Lutz","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1002\/14651858.CD011367.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1212\/WNL.0b013e3182840b95","article-title":"Postinfectious neurologic syndromes: a prospective cohort study","volume":"80","author":"Marchioni","year":"2013","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2377-8-40","article-title":"Protocol for German trial of Acyclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]","volume":"8","author":"Martinez-Torres","year":"2008","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1524-4733.2004.71273.x","article-title":"Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues","volume":"7","author":"Matza","year":"2004","journal-title":"Value in Health"},{"issue":"4","key":"10.1002\/14651858.CD011367.pub2-BIB0064|cit64","first-page":"435","article-title":"Molecular control of immune\/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways","volume":"20","author":"McKay","year":"1999","journal-title":"Endocrine Reviews"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(01)02469-7","article-title":"Experimental herpes simplex virus encephalitis: inhibition of the expression of inducible nitric oxide synthase in mouse brain tissue","volume":"318","author":"Meyding-Lamad\u00e9","year":"2002","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-3083.1995.tb03591.x","article-title":"Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties","volume":"41","author":"Mollnes","year":"1995","journal-title":"Scandinavian Journal of Immunology"},{"issue":"3","key":"10.1002\/14651858.CD011367.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/fvl.12.138","article-title":"The case for immunomodulatory approaches in treating HSV encephalitis","volume":"8","author":"Ramakrishna","year":"2013","journal-title":"Future Virology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3851\/IMP2683","article-title":"A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: is timing critical for safety and efficacy?","volume":"19","author":"Ramos-Estebanez","year":"2014","journal-title":"Antiviral Therapy"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0069|cit69","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0070|cit70","first-page":"121","article-title":"Assessment of effective intervention","volume-title":"Behavior Assessment System for Children (BASC-2)","volume":"32","author":"Reynolds","year":"2004"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0071|cit71","first-page":"311","article-title":"Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins","volume":"74","author":"Rossi","year":"1988","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/B978-0-444-52910-7.00038-6","article-title":"Acute viral encephalitis","volume":"112","author":"Rozenberg","year":"2013","journal-title":"Handbook of Clinical Neurology \/ Edited by P.J. Vinken and G.W. Bruyn"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neulet.2004.10.054","article-title":"Acute and long-term alteration of chemokine mRNA expression after anti-viral and anti-inflammatory treatment in herpes simplex virus encephalitis","volume":"374","author":"Sellner","year":"2005","journal-title":"Neuroscience Letters"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/511987","article-title":"Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice","volume":"195","author":"Sergerie","year":"2007","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD011367.pub2-BIB0075|cit75","first-page":"389","article-title":"Vineland adaptive behavior scales. American Guidance Service, Circle Pines","volume":"23","author":"Sparrow","year":"1986","journal-title":"Journal of Educational Measurement"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0076|cit76","volume-title":"Vineland Screener: Overview, Reliability, Validity, Administration and Scoring. Interview Edition, Survey Form Manual","author":"Sparrow","year":"1993"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/08820139709088541","article-title":"Immunoglobulins for intravenous use inhibit TNF alpha cytotoxicity in vitro","volume":"26","author":"Stangel","year":"1997","journal-title":"Immunological Investigations"},{"issue":"12","key":"10.1002\/14651858.CD011367.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.it.2008.08.004","article-title":"Modulation of the cellular immune system by intravenous immunoglobulin","volume":"29","author":"Tha-In","year":"2008","journal-title":"Trends in Immunology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/13550280009006379","article-title":"Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal herpes encephalitis","volume":"6","author":"Thompson","year":"2000","journal-title":"Journal of Neurovirology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/archdischild-2011-300100","article-title":"Encephalitis in children","volume":"97","author":"Thompson","year":"2012","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1002\/14651858.CD011367.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurology"},{"issue":"8","key":"10.1002\/14651858.CD011367.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2012-11-468264","article-title":"Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells","volume":"122","author":"Trinath","year":"2013","journal-title":"Blood"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0083|cit83","unstructured":"UK Trialists Individual patient data (as supplied 30 April 2013) Data on File"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0084|cit84","doi-asserted-by":"crossref","unstructured":"van Swieten JC Koudstaal PJ Visser MC Schouten HJ van Gijn J Interobserver agreement for the assessment of handicap in stroke patients Stroke 1988 604 7","DOI":"10.1161\/01.STR.19.5.604"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0085|cit85","doi-asserted-by":"crossref","unstructured":"Varni JW Seid M Rode CA The PedsQL\u2122: measurement model for the pediatric quality of life inventory Medical Care 1999 126 39","DOI":"10.1097\/00005650-199902000-00003"},{"issue":"8","key":"10.1002\/14651858.CD011367.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD011367.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1212\/WNL.0000000000000086","article-title":"Burden of encephalitis-associated hospitalizations in the United States, 1998-2010","volume":"82","author":"Vora","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011367.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcv.2006.05.009","article-title":"Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis","volume":"37","author":"Wang","year":"2006","journal-title":"Journal of Clinical Virology"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0089|cit89","volume-title":"Wechsler Preschool and Primary Scale of Intelligence (WPPSI - III)","author":"Wechsler","year":"2002"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0090|cit90","volume-title":"Wechsler Intelligence Scale for Children (WISC-IV)","author":"Wechsler","year":"2003"},{"key":"10.1002\/14651858.CD011367.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp-2011-301237","article-title":"Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition","volume":"83","author":"Zuliani","year":"2012","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011367.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T16:18:15Z","timestamp":1682957895000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011367.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":91,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011367.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,2]]}}}